These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7552482)

  • 1. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):175-6. PubMed ID: 7552482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV incidence among needle exchange participants: estimates from syringe tracking and testing data.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr (1988); 1994 Feb; 7(2):182-9. PubMed ID: 8301530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange?
    Kaplan EH; Khoshnood K; Heimer R
    Am J Public Health; 1994 Dec; 84(12):1991-4. PubMed ID: 7998644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV prevalence among intravenous drug users: model-based estimates from New Haven's legal needle exchange.
    Kaplan EH; Heimer R
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):163-9. PubMed ID: 1732509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.
    Heimer R
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S65-73. PubMed ID: 18207726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for evaluating needle exchange programmes.
    Kaplan EH
    Stat Med; 1994 Oct 15-30; 13(19-20):2179-87. PubMed ID: 7846418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange program.
    Khoshnood K; Kaplan EH; Heimer R
    Public Health Rep; 1995; 110(4):462-6. PubMed ID: 7638334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe use and reuse: effects of syringe exchange programs in four cities.
    Heimer R; Khoshnood K; Bigg D; Guydish J; Junge B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S37-44. PubMed ID: 9663622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
    van Beek I; Chronister KJ
    Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users.
    Heimer R; Myers SS; Cadman EC; Kaplan EH
    J Infect Dis; 1992 Apr; 165(4):781-2. PubMed ID: 1552214
    [No Abstract]   [Full Text] [Related]  

  • 13. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of needle exchange-based health services on emergency department use.
    Pollack HA; Khoshnood K; Blankenship KM; Altice FL
    J Gen Intern Med; 2002 May; 17(5):341-8. PubMed ID: 12047730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study finds legalizing needles reduces HIV risk.
    AIDS Policy Law; 1995 Sep; 10(17):1, 11. PubMed ID: 11362806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
    Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
    Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.